v3.26.1
Operating expenses (Details) - USD ($)
$ in Thousands
 12 Months Ended
Dec. 31, 2025
Dec. 31, 2024
Operating expenses    
Stock-based compensation expense $ 3,235 $ 1,641
Research and development    
Operating expenses    
Salaries and management fees 3,359 2,687
Discovery expenses 682 698
Preclinical expenses 2,160 5,420
Chemistry, manufacturing controls 1,117 2,495
Clinical expenses 9,600 2,459
Stock-based compensation expense 1,508 600
Operating expenses 18,426 14,359
General and administrative    
Operating expenses    
Salaries and management fees 3,337 2,723
Professional fees 2,374 1,688
Other operating expenses 590 572
Stock-based compensation expense 1,727 1,041
Depreciation 5 15
Operating expenses $ 8,033 $ 6,039